These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9819522)

  • 1. Use of combination antiretroviral therapy in pregnant women with HIV disease.
    Newshan G; Hoyt MJ
    MCN Am J Matern Child Nurs; 1998; 23(6):307-12; quiz 313. PubMed ID: 9819522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy in the pregnant woman.
    Augenbraun M; Minkoff HL
    Obstet Gynecol Clin North Am; 1997 Dec; 24(4):833-54. PubMed ID: 9430170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy.
    Grubert TA; Wintergerst U; Lutz-Friedrich R; Belohradsky BH; Rolinski B
    AIDS; 1999 Jul; 13(11):1430-1. PubMed ID: 10449309
    [No Abstract]   [Full Text] [Related]  

  • 6. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance.
    Gingelmaier A; Eberle J; Kost BP; Bogner JR; Hofmann J; Weissenbacher T; Kästner R; Friese K; Weizsaecker K
    Clin Infect Dis; 2010 Mar; 50(6):890-4. PubMed ID: 20166821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of human immunodeficiency virus infection in pregnancy.
    Watts DH
    N Engl J Med; 2002 Jun; 346(24):1879-91. PubMed ID: 12063373
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges.
    Shannon M
    J Perinat Neonatal Nurs; 2002 Sep; 16(2):1-25. PubMed ID: 12233942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral Pharmacokinetics in Pregnant Women.
    Gilbert EM; Darin KM; Scarsi KK; McLaughlin MM
    Pharmacotherapy; 2015 Sep; 35(9):838-55. PubMed ID: 26297552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy during pregnancy. Beyond AZT (ZDV).
    Dattel BJ
    Obstet Gynecol Clin North Am; 1997 Sep; 24(3):645-57. PubMed ID: 9266584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antiretroviral therapy in 100 HIV-1-infected pregnant women.
    Bucceri AM; Somigliana E; Matrone R; Ferraris G; Rossi G; Grossi E; Vignali M
    Hum Reprod; 2002 Feb; 17(2):436-41. PubMed ID: 11821291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in pregnancy: a focus on safety.
    Taylor GP; Low-Beer N
    Drug Saf; 2001; 24(9):683-702. PubMed ID: 11522121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of perinatal HIV transmission during pregnancy.
    McGowan JP; Shah SS
    J Antimicrob Chemother; 2000 Nov; 46(5):657-68. PubMed ID: 11062184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral medications during pregnancy for therapy or prophylaxis.
    Stek AM
    Curr HIV/AIDS Rep; 2009 May; 6(2):68-76. PubMed ID: 19358777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.